Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP.

EMBO J. 2001 Mar 15;20(6):1331-40.

2.

Dynamics of the p53 acetylation pathway.

Gu W, Luo J, Brooks CL, Nikolaev AY, Li M.

Novartis Found Symp. 2004;259:197-205; discussion 205-7, 223-5. Review.

PMID:
15171255
3.

p300/CBP/p53 interaction and regulation of the p53 response.

Grossman SR.

Eur J Biochem. 2001 May;268(10):2773-8. Review.

4.

Regulation and activation of p53 and its family members.

Lohrum MA, Vousden KH.

Cell Death Differ. 1999 Dec;6(12):1162-8. Review.

PMID:
10637431
5.

To die or not to die: a HAT trick.

Tyteca S, Legube G, Trouche D.

Mol Cell. 2006 Dec 28;24(6):807-8. Review.

6.

C-Abl as a modulator of p53.

Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. Review.

PMID:
15865930
7.

P53 licensed to kill? Operating the assassin.

Haupt S, Louria-Hayon I, Haupt Y.

J Cell Biochem. 2003 Jan 1;88(1):76-82. Review.

PMID:
12461776
8.

Novel activators of the tumour suppressor p53.

Sunder-Plassmann N, Giannis A.

Chembiochem. 2004 Dec 3;5(12):1635-7. Review. No abstract available.

PMID:
15526327
9.

Post-translational modification of p53 in tumorigenesis.

Bode AM, Dong Z.

Nat Rev Cancer. 2004 Oct;4(10):793-805. Review.

PMID:
15510160
10.

Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks.

Benkirane M, Sardet C, Coux O.

Biochem Soc Trans. 2010 Feb;38(Pt 1):98-103. doi: 10.1042/BST0380098. Review.

PMID:
20074043
11.

p53 Acetylation: Regulation and Consequences.

Reed SM, Quelle DE.

Cancers (Basel). 2014 Dec 23;7(1):30-69. doi: 10.3390/cancers7010030. Review.

Supplemental Content

Support Center